CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Eagle Pharmaceuticals, Inc. v. Baxter Healthcare Corporation

1:25-cv-00079

Overview

Case Number 1:25-cv-00079
Filing Date 2025-01-17
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Baxter Healthcare Corporation NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Eagle Pharmaceuticals, Inc. Operating Company

Represented By

3 Attorneys Listed

Maliheh Zare

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 984-6399

405 N. King Street, Wilmington, DE 19801

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 13 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (13): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US12138248
Formulations of bendamustine
Filed: 2024-04-25
Issued: 2024-11-12
Active (17.4 yrs remaining)
Expires: 2044-04-25

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked.

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

5

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 5

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending
SO ORDERED, re (17 in 1:25-cv-00074-JLH, 17 in 1:25-cv-00075-JLH, 19 in 1:25-cv-00079-JLH) Stipulation and Order to Extend Time for the parties to submit a Prop...
Entry #β€” • 2025-05-15
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a (i) Proposed Scheduling Order and (ii) and Joint Letter to May 21, 2025 - filed by Eagle Pharmaceuticals,...
Entry #19 • 2025-05-14 Document →
Procedural / Extension Motion Pending
SO ORDERED, re (17 in 1:25-cv-00079-JLH, 16 in 1:25-cv-00074-JLH, 16 in 1:25-cv-00075-JLH) Stipulation and Order to Extend Time for the parties to submit a Prop...
Entry #β€” • 2025-05-07
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a (i) Proposed Scheduling Order and (ii) and Joint Letter to May 14, 2025 - filed by Eagle Pharmaceuticals,...
Entry #17 • 2025-05-06 Document →
Procedural / Extension Motion Pending / Under Review
Stipulation to EXTEND Time
Entry #16 • 2025-04-23 Document →

Docket Entries

(47 total)
Pleading / Complaint

COMPLAINT for Patent Infringement with Jury Demand against Baxter Healthcare Corporation (Filing fee $ 405, receipt number ADEDC-4593989) - filed by Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Entered: 01/17/2025)

Entry #1 • 2025-01-17
1
Pleading / Complaint

COMPLAINT for Patent Infringement with Jury Demand against Baxter Healthcare Corporation (Filing fee $ 405, receipt number ADEDC-4593989) - filed by Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Entered: 01/17/2025)

Entry #1 • 2025-01-17
2
Pleading / Complaint

COMPLAINT for Patent Infringement with Jury Demand against Baxter Healthcare Corporation (Filing fee $ 405, receipt number ADEDC-4593989) - filed by Eagle Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Entered: 01/17/2025)

Entry #1 • 2025-01-17
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 01/17/2025)

Entry #2 • 2025-01-17
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,138,248. (jfm) (Entered: 01/17/2025)

Entry #3 • 2025-01-17
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc